Former UFC Middleweight Champion Anderson Silva has been notified by the United States Anti-Doping Agency (USADA) of a potential violation and he has been pulled from the main event of UFC Fight Night Shanghai.
The career of UFC legend Anderson Silva hangs in the balance after the UFC announced in a short news release that Silva failed an out-of-competition drug test given on October 26.
The UFC states it is now looking for a replacement opponent for Gastelum, who is set to headline UFC Fight Night 122 in Shanghai. The two were first scheduled to meet at UFC 212 this summer in Brazil, but Gastelum was removed after testing positive for marijuana in his drug test.
The substance he tested positive in the latest failure won’t be publicly revealed until he goes through his hearing process and final discipline is decided on.
Silva could face up to a four-year suspension as he is now considered a repeat offender, but a thorough investigation will happen before punishment is given.
During his disciplinary hearing with the NSAC, Silva maintained his innocence and said the failed tests were the result of an unmarked sexual-enhancement drug he received from Thailand. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed.
It would be a sad and ignominious way to end a spectacular career if Silva were to be found guilty of this violation.
This marks the second time in almost three years that Silva has been flagged for a potential violation, with his first coming back in January 2015.
The Brazilian legend tested positive for the anabolic steroid drostanolone, androstane and banned anti-anxiety medication. “It would certainly be a potent performance enhancer, particularly in a combat sport”.